Loading...
Drug Resistance to EGFR Inhibitors in Lung Cancer
BACKGROUND: The discovery of mutations in epidermal growth factor receptor (EGFR) has dramatically changed the treatment of patients with non-small cell lung cancer (NSCLC)—the leading cause of cancer death worldwide. EGFR-targeted therapies show considerable promise, but drug resistance has become...
Na minha lista:
| Udgivet i: | Chemotherapy |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4844777/ https://ncbi.nlm.nih.gov/pubmed/26910730 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000443368 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|